SCHEMBL12960069

SCHEMBL12960069

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5cc(-c6ccccc6)cc(-c6ccccc6)c5)cc4)c4cccc5c4sc4ccccc45)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.43
▸ TNKS O95271 1/20 0.40
▸ TNKS2 Q9H2K2 1/20 0.40
▸ GPR3 P46089 1/20 0.36
▸ LIMK1 P53667 2/20 0.35
▸ F9 P00740 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ PARP14 Q460N5 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PTPN1 P18031 3/20 0.32
▸ PIM3 Q86V86 2/20 0.32
▸ APP P05067 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12960075 1.00 ALOX5 (0.43) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL12960078 0.99 ALOX5 (0.42) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL14295393 0.99 ALOX5 (0.42) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL17126477 0.97 ALOX5 (0.41) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL22155833 0.97 ALOX5 (0.41) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL12960032 0.97 ALOX5 (0.43) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL17126454 0.97 ALOX5 (0.43) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL17126465 0.97 ALOX5 (0.43) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL14295401 0.96 ALOX5 (0.42) ALOX5TNKSTNKS2GPR3LIMK1
SCHEMBL6372548 0.96 ALOX5 (0.42) ALOX5TNKSTNKS2GPR3LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278926-B2 Aromatic amine derivative, and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-08 — — US disclosed
US-9278926-B2 Aromatic amine derivative, and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-08 — — US disclosed
US-20120248426-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-10-04 — — US disclosed
US-20120248426-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-10-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120248426-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AOC2, AHR, AOC3 ALOX5 694/4885TNKS 4145/4885TNKS2 4012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback